News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

COVID-19 update from Cellectricon

In light of the COVID-19 pandemic, we wish to inform you that we remain open for business and are progressing the...

Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research

Mölndal, Sweden and Victoria, BC, Canada Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the...

Towards “disease in a dish” microfluidic models for studying the interaction of bone and neuronal cells

In August, Cellectricon welcomed our new coworker Lydia Moll. Lydia will carry out her PhD project at the company over...

Sign up to get news & events updates from Cellectricon

Dr. Thomas Nieland joins Cellectricon’s advisory board

Cellectricon has appointed Dr. Thomas Nieland, Research Associate Professor at the Biomedical Engineering Department of Tufts University, to its scientific...

Cellectricon to collaborate with world-renowned pain scientists in the EU-funded Bone Pain Network

Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative...

A 4-year PhD position - In vitro modelling of chronic pain - available as a collaboration between Cellectricon and Karolinska Institutet

Background: We are looking for a new colleague – a driven PhD student with previous experience gained from the pharmaceutical...

Sign up to get news & events updates from Cellectricon

Join our team! Cellectricon is looking for an experienced laboratory assistant to support our ongoing customer projects

Cellectricon is an innovative discovery services provider in the areas of chronic pain and CNS in vitro research. We are...

Cellectricon announces new opportunity for the discovery of highly differentiated therapeutics for neurodegenerative diseases

Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of neurodegenerative...

Henrik Zetterberg joins Cellectricon's advisory board

Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and CNS...

1 2 3 4 5 6 … 8